Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? – A retrospective study
Abstract Background Equine glandular gastric disease (EGGD) is a common condition of the horse. Misoprostol is reported to be superior to oral omeprazole and sucralfate for treatment. Long‐acting intramuscular injectable omeprazole (LAIOMEP) is a novel treatment shown to be effective in a small popu...
Main Authors: | S. L. Pratt, M. Bowen, G. H. Hallowell, E. Shipman, J. Bailey, A. Redpath |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Veterinary Medicine and Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/vms3.1034 |
Similar Items
-
Assessment of agreement using the equine glandular gastric disease grading system in 84 cases
by: Stefanie Pratt, et al.
Published: (2022-07-01) -
Equine Gastric Ulcer Syndrome: An Update on Current Knowledge
by: Jessica Vokes, et al.
Published: (2023-04-01) -
Effects of corn oil on the volatile fatty acids in horses with induced gastric ulcers
by: José Martínez A, et al.
Published: (2016-09-01) -
Changes in Calprotectin (S100A8-A9) and Aldolase in the Saliva of Horses with Equine Gastric Ulcer Syndrome
by: Alberto Muñoz-Prieto, et al.
Published: (2023-04-01) -
Gastric microbiome in horses with and without equine glandular gastric disease
by: Linda J. Paul, et al.
Published: (2021-09-01)